Choi, Y.J.; Kim, D.W.; Shin, M.J.; Yeo, H.J.; Yeo, E.J.; Lee, L.R.; Song, Y.; Kim, D.-S.; Han, K.H.; Park, J.;
et al. PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson’s Disease. Molecules 2021, 26, 3329.
https://doi.org/10.3390/molecules26113329
AMA Style
Choi YJ, Kim DW, Shin MJ, Yeo HJ, Yeo EJ, Lee LR, Song Y, Kim D-S, Han KH, Park J,
et al. PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson’s Disease. Molecules. 2021; 26(11):3329.
https://doi.org/10.3390/molecules26113329
Chicago/Turabian Style
Choi, Yeon Joo, Dae Won Kim, Min Jea Shin, Hyeon Ji Yeo, Eun Ji Yeo, Lee Re Lee, Yejin Song, Duk-Soo Kim, Kyu Hyung Han, Jinseu Park,
and et al. 2021. "PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson’s Disease" Molecules 26, no. 11: 3329.
https://doi.org/10.3390/molecules26113329
APA Style
Choi, Y. J., Kim, D. W., Shin, M. J., Yeo, H. J., Yeo, E. J., Lee, L. R., Song, Y., Kim, D.-S., Han, K. H., Park, J., Lee, K. W., Park, J. K., Eum, W. S., & Choi, S. Y.
(2021). PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson’s Disease. Molecules, 26(11), 3329.
https://doi.org/10.3390/molecules26113329
